PANL Virtual Continuing Education Program – Session Topics, Speakers and Dates!

PANL is pleased to offer a Virtual CE Program this September in lieu of the traditional PANL Annual Conference. Registered participants will have the opportunity to earn a similar number of CE credits as the PANL conference would normally provide.

The sessions will be presented live via Zoom Webinar and, when possible, recorded for registered participants to view at a later time. Sessions will be delivered during the week (evenings) with morning sessions during the weekends.

Session descriptions, speakers and dates are below. Additional sessions may be added and dates/time are subject to change. Registration will open early in August – stay tuned for details! [Download Conference Schedule]

SESSION: Lessons Learned From the COVID-19 Pandemic and Implications for Pandemic Preparedness

Date and Time:
Wednesday, September 9, 2020
8:00 p.m. to 9:00 p.m.

Presentation Details:
Pharmacists are Canadians’ most accessible health care providers. This has never been more evident that during the COVID-19 pandemic. Community pharmacies remained open, with pharmacists continuing to provide essential medication management care to patients, while other health care providers closed their doors. However, the pandemic has presented community pharmacy with many practice challenges including procurement of PPE; maintaining continuity of care for patients; managing drug shortages; providing care to a surge of patients seeking help – all while maintaining heightened infection control measures. Undeniably, it is essential to incorporate early lessons learned from the COVID-19 pandemic to help pharmacists be better prepared for the upcoming pandemic or wave. This presentation will highlight key strategies and considerations in achieving patient continuity of care, safeguarding medication supply, and optimizing workflow to protect staff and patients. While it’s impossible to prevent a pandemic from occurring, there is much pharmacists can do in preparation.

The learning objectives for this presentation include:

  • Identify the various roles pharmacists play during a pandemic
  • Discuss changes to workflow and practice to protect pharmacy members and patients
  • List challenges to continuity of care and describe solutions to overcoming these barriers
  • Identify legislative changes to pharmacists’ scope to facilitate care during a pandemic

Presented by:
Shelita Dattani, BSc (Pharm), Pharm D

About the presenter:

Shelita received her bachelor of science in pharmacy from Northeastern University and her Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill. During her career, she has worked in numerous practice settings including hospital, community, academic, and industry in the US and Canada where she has led dynamic teams towards excellence in effective and safe best medication practice. Sheli has also held teaching appointments at the University of Ottawa and has precepted students at the University of Waterloo and University of Toronto and has a passion for teaching future leaders in the profession. She has authored several articles and book chapters and has presented in various capacities at local and national conferences.

Sheli is currently the Director, Practice Development and Knowledge Translation, at the Canadian Pharmacists Association. She leads the professional affairs group at the Canadian Pharmacist Association and is responsible for leading evidence informed practice advancement and development initiatives for the advancement of pharmacists practice in Canada.  She also holds an active pharmacist license in the province of Ontario, maintains a part-time practice in community pharmacy and remote hospital telepharmacy, and is a member of several professional organizations. Sheli has a strong interest and passion for advancement of the pharmacy profession in the provision of excellence in patient care.

SESSION: Changing Trajectory: Making an Early Impact on Type 2 Diabetes

This session is ‘live’ only and will not be recorded and made available at a later date.

Date and Time:
Thursday, September 10, 2020
8:00 p.m. to 9:00 p.m.

Presentation Details: 

This presentation will help participants recognize the benefits of achieving early control, compare anti-hyperglycemics with a focus on the oral option, discuss practical considerations for integrating new treatments earlier, and self-reflect on their current practice and identify opportunities to optimize patient care.

Presented by: 

Rob Roscoe, BSc. (Pharm), ACPR, CDE, CPT

About the presenter:

A graduate from Dalhousie University, (1984) Mr. Roscoe completed his Hospital Pharmacy Residency at Saint John Regional Hospital(1985) and worked in various hospitals in the New Brunswick region before finding his place in community pharmacy (one location for 27 years).

He now provides collaborative diabetes clinics (last seven years) within family practitioners offices seeing individual patients as part of his innovative practice.

Mr. Roscoe has a long list of accomplishments in the field.

  • One of the co-authors/expert committee members of the 2013 CDA Clinical Practice Guidelines and the DC (Diabetes Canada) 2018 Guidelines.
  • He is on the Board of Directors of the Canadian Diabetes Educator Certification Board,
  • He is one of the founding board members and an author of the Forum for Injection Technique in Canada (FIT)
  • He has represented the pharmacist’s role in a patient’s diabetes care team for a Discovery Channel special
  • Recently Published in International Journal of Diabetes as one of the writing team for article “Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes. 2018
  • He also is the lead author in a number of accredited CME (Continuing Medical Education) programs.

SESSION: Protect Your Resilience: How to Reduce Anxiety and Lower Burnout in the Workplace

Date and Time:
Saturday, September 12, 2020
10:00 a.m. to 12:00 p.m.

Presentation Details:
How resilient are you? It’s a question worth asking. Our ability to be resilient, or bounce back, can have a significant influence on how we manage stress and interact with our colleagues and clients, on our mental and physical health, and, ultimately, on our success.
The good news is that resilience in the workplace and in life can be built and improved. This session provides research-based tips to help you build and protect your resilience and support the resilience of others, whether at work or in your personal life. You may be surprised at how applying some basic principles of cognitive behavioural research can produce positive results in your life.

The learning objectives for this session include:

  • Identify warning signs that your resilience is low and the potential implications for you, your team and the organization
  • Understand the links between physical, mental and financial health
  • Learn how to implement practical, research-based tools to both build and retain your resilience

Presented by:
Marie-Hélène Pelletier, PhD, MBA, Rpsych

About the presenter:

Throughout her career in business management and psychology, Dr. Marie-Hélène Pelletier has spearheaded a national dialogue on the crucial issues of leadership resilience and workplace health. Drawing on her extensive background in corporate, insurance, governance and public sectors, she brings national and international perspectives and expertise on mental health and resilience as a key pillar of overall health. She is a bilingual practicing psychologist with over 20 years of experience in clinical, counselling, and advisory workplace psychology and holds a Ph.D. in counselling psychology from the University of British Columbia and an MBA from the UBC Sauder School of Business. Marie-Helene is a Member of the Global Clinical Practice Network of the World Health Organization, and past Director on the boards of the Canadian Psychological Association and the International Association of Applied Psychology. She has presented and authored and co-authored a number of industry and academic publications and was won numerous academic and industry awards, including the Industry Leadership Award from Benefits Canada. Find out more at drmhpelletier.com

SESSION: What’s New in Pneumonia, COPD and Asthma Management?

Date and Time:
Tuesday, September 15, 2020
8:00 p.m. to 9:00 p.m.

Presentation Details:
The learning objectives for this presentation include:

  • Understand changes to pharmacotherapy in Community Acquired Pneumonia, Chronic Obstructive Pulmonary Disease and Asthma.
  • Understand the evidence behind these changes
  • Learn how to incorporate these changes into everyday practice.

Presented by:
John Hawbolt, BSc (Pharm.), ACPR, Pharm D

About the presenter:

John graduated from the University of Saskatchewan in 1992, completed a Hospital Pharmacy Residency at Alberta Children’s Hospital the following year and completed a Doctor of Pharmacy from the University of Washington in 2004. In between all of that, he has worked in a variety of patient care areas in both hospital and community settings. John joined the Faculty at the School of Pharmacy at MUN in 2004. He is currently also cross-appointed to the Department of Pharmacy and Respirology at EH and MUN. He has an interest in antimicrobial stewardship and serves on both the Eastern Health and the Provincial Committees. Primary areas of interest in teaching and research include infectious diseases and respirology.

SESSION: Current and Emerging Treatment Options for Opioid Use Disorder and Application of NLPB Standards of Practice for OAMT

Date and Time:
Wednesday, September 16, 2020
8:00 p.m. to 9:00 p.m.

Presentation Details:
This presentation will start with a review of current and emerging treatment options for opioid use disorder (OUD). At the end of the presentation, clarifications will be provided regarding NLPB Standards of Practice for Safe and Effective Provision of Opioid Agonist Maintenance Treatment.

The learning objectives for the presentation include:

  • Understand the role of methadone and buprenorphine naloxone in the treatment of OUD
  • Be familiar with emerging/non-conventional medications for treatment of OUD including:
    • Slow release oral morphine (SROM, e.g. KADIAN®)
    • Injectable opioid agonist treatment
    • Injectable diacetylmorphine (DAM, HEROIN)
    • Injectable hydromorphone
    • Buprenorphine dept injection (SUBLOCADE®)
    • Buprenorphine implant (PROBUPHINE®)
  • Understand the application of NLPB Standards of Practice for provision of OAMT

Presented by:
Stephanie Delaney, BSc (Pharm), RPh
Noelle Patten, BSc (Pharm), RPh, MHM, CHE

About the presenters:

Stephanie Delaney is a full-time pharmacist practicing in St. John’s. She splits her time between the Opioid Treatment Centre/Recovery Centre in Pleasantville and NuCare Pharmacy, providing pharmacy services to several long-term care facilities in the St John’s metro area. She obtained her BSc Pharm from Memorial University in 2010 and will be completing her PharmD through MUN in spring 2021.

Noelle Patten is Associate Registrar- Quality Assurance at the Newfoundland and Labrador Pharmacy Board (NLPB). Noelle graduated from the Memorial University School of Pharmacy in 2006, completed a Masters in Health Management at McMaster University in 2018, and achieved a Certified Health Executive Designation with the Canadian College of Health Leaders in 2019.  Noelle started her career in community pharmacy, which she enjoyed for eight years. She joined NLPB in 2014, initially as a practice advisor and moved into her current role in 2015. Her primary responsibility is development and oversight of the NLPB Quality Assurance Program, which includes practice site assessment programs for community and hospital pharmacies, and professional development requirements for registrants. Noelle also oversees registration and licencing processes and assists with the development and implementation of regulatory standards and guidelines. In terms of management of opioid use disorder, Noelle practiced in this area during her time as a community pharmacist. Noelle completed the Centre for Addiction and Mental Health (CAMH) Opioid Dependence Treatment Certificate Program in 2017.

Noelle is the team lead for NLPB Standards for Safe and Effective Provision of Opioid Agonist Maintenance Treatment, and a long-standing representative on the Provincial Opioid Dependence Treatment Advisory Group. She has also participated in various national projects; most recently the development of interprofessional education guidelines for opioid use and opioid use disorder for nurses, social workers, and pharmacists.

SESSION: Herpes Zoster Vaccination and Vaccination Concerns Related to the COVID-19 Pandemic

Date and Time:
Sunday, September 20, 2020
10:00 a.m. to 11:00 a.m.

Presentation Details:
The learning objectives for this session include:

  • Understand NACI recommendations regarding the prevention of HZ and how to apply these recommendations to your patients
  • Communicate the benefits of vaccination and answer questions from patients, families and caregivers regarding the efficacy and safety of the HZ vaccine
  • Understand interim guidance on continuity of immunization programs during the COVID
  • Review implementation strategies for community-based immunization practices during COVID

Presented by:
Dr. Kathy Slayter

About the presenter:

Dr. Kathy Slayter is currently Assistant Professor with the Faculty of Medicine, Division of Infectious Diseases and Faculty of Graduate Studies at Dalhousie University and Clinical Pharmacy Specialist, Infectious Diseases and Antimicrobial Stewardship at the IWK Health Center. She was the first non-physician in Canada to have completed an Associateship with the Canadian HIV Clinical Trials Network and Canadian Institute for Health Research (CIHR), where her research focused on vaccination strategies in HIV infected patients. In addition, she is co-lead of the Antimicrobial Stewardship Program at the IWK Health Centre.

She has received numerous awards for her antimicrobial stewardship efforts including the Nova Scotia Quality Summit Award for the development of the AMS Program at the IWK. Her work was highlighted at a recent Canadian Patient Safety Institute Board Reception on behalf of the IWK to showcase the development of the IWK Antimicrobial Stewardship Application in Spectrum, the first AMS App developed for a Pediatric and Women’s Health Hospital in Canada and the first App developed by the IWK. Dr. Slayter is also a clinical scientist with the Canadian Center for Vaccinology (CCfV) and Canadian Immunization Research Network (CIRN) and is an avid researcher and has published extensively in the area of immunization. In her free time, she has helped to train and certify over 600 pharmacists in the Dalhousie College of Pharmacy’s Immunization and Injection Administration Training Program which she also co-developed.

SESSION: ‘Anti-Vaxx’ and Everything in Between: Vaccine Hesitancy in Pharmacy Practice

Date and Time:
Sunday, September 20
11:15 a.m. to 12:15 p.m.

Presentation Details:
The learning objectives for this session include:

  • Identify factors contributing to vaccine hesitancy
  • Distinguish between vaccine hesitancy and being an ‘anti-vaxxer’
  • Identify a person’s current position regarding vaccination
  • Tailor a conversation on vaccination to the needs and perspective of the patient
  • Describe strategies to encourage and support vaccine acceptance

Presented by:
Sherilyn Houle, BSc (Pharm), PhD

About the presenter:

Sherilyn received her pharmacy degree from the University of Saskatchewan, and PhD from the University of Alberta. She also holds her Certificate in Travel Health from the International Society of Travel Medicine. She has experience in hospital, home care, and community pharmacy practice, and is currently an Assistant Professor at the University of Waterloo School of Pharmacy. She also maintains a practice at the International Travel and Immunizations Clinic at the Centre for Family Medicine Family Health Team in Kitchener, Ontario. Sherilyn's research, teaching, and practice interests are on pharmacist practice to full scope, with particular focus on pharmacists as immunizers and travel medicine care providers.

SESSION: Integrating Innovative Clinical Programs Into Community Pharmacy: A Novel Approach to Improve Patient Care

Date and Time:
Wednesday, September 25
8:00 p.m. to 9:00 p.m.

Presentation Details:

The presentation is intended to assist pharmacists with integrating a suite of sustainable enhanced clinical programs into a busy community pharmacy practice. The program will review novel services including pharmacogenomics, point-of-care testing, and immunization and the current evidence that supports the value of implementation. Strategies to overcome common barriers and workflow issues will also be discussed.


Objectives:

  • Review the novel, enhanced clinical programs available for implementation into practice by community pharmacists.
  • Discuss strategies to overcome barriers when attempting to integrate clinical services into a busy community pharmacy practice.
  • Showcase recent evidence that highlights the benefits of pharmacist-directed enhanced services in the management of different disease states.
  • Review workflow strategies and methods of engaging staff to ensure sustainability.

Presented by:
John Papastergiou, BSc(Pharm)

About the presenter:

John Papastergiou graduated from the Leslie Dan Faculty of Pharmacy, University of Toronto in 2002. After graduation he was employed as a staff pharmacist at Sunnybrook Health Sciences Center. In 2005, John joined Shoppers Drug Mart and acquired his first store at Pape and Danforth. He now owns and operates four locations in downtown Toronto. In 2014, John received an appointment as an adjunct assistant professor at the School of Pharmacy, University of Waterloo. In 2016, he was cross appointed at the Leslie Dan Faculty of Pharmacy, University of Toronto.

In addition to managing a large business, John employs his unique background in clinical research to explore an expanded role for the community pharmacist. John strongly believes that the accessibility of the community pharmacist places them in a unique position to actively screen and monitor patients for various chronic diseases. Most recently, he implemented one of the first frontline community pharmacist-directed pharmacogenomics clinics in Canada. His work in this area won first prize at the 76th FIP World Congress of Pharmacy and Pharmaceutical Sciences in Buenos Aires, Argentina.

John can be heard regularly on the Libby Fights Back Show on AM740 Zoomer Radio and on his top-rated podcast The Pharmacists Are In.

In 2012, John was named the Shoppers Drug Mart Associate of the Year. In 2014, he received the OPA Mentorship Award and was named CPhA Canadian Pharmacist of the Year. In 2016, he was the recipient of the OPA Voice of the Profession Award and was awarded the Pharmacy Practice Commitment to Care Award for Overall Patient Care. In 2019, John was named by the International Forum on Advancement in Healthcare as one of the top 100 healthcare leaders globally. He was also presented with the OPA Award for Excellence in Research and Academia. In 2020 he was the recipient of the inaugural Leslie Dan Faculty of Pharmacy, University of Toronto Alumni Leadership Award.

SESSION: Non-Sterile Compounding Standards Implementation: Are You on the Right Track?

Date and Time:
Thursday, September 24, 2020
8:00 p.m. to 9:00 p.m.

Presentation Details:
The goal of this session is to answer frequently asked questions about NLPB non-sterile compounding standards and guidelines and provide guidance for implementation, form both a regulatory and practical perspective. This should enable participants to self-assess their implementation activities and adjust their approach where necessary.

Upon completion, pharmacists should have a better understanding of:

  • Why it is important for pharmacies that provide any level of compounding to focus on quality and safety improvements
  • How to appropriately implement non-sterile compounding standards, including policy and procedure development, staff training, conducting and documenting risk assessments, and creating master formulation records
  • Application of the NLPB Standards and Guidelines for Pharmacy Compounding of Non-Sterile Preparation (NLPB will review FAQs)

Presented by:
Heather Warren, BSc (Pharm)
Noelle Patten, BSc (Pharm), MHM, CHE

About the presenters:

Heather Warren is the Non-Sterile Compounding Supervisor of Compounding Wellness Pharmacy. Heather graduated from Memorial University of Newfoundland with a Bachelor of Science (Pharmacy) in 2005 and began her career in community pharmacy at this time.  Heather started working with Compounding Wellness Pharmacy over three years ago. Here she completed further education in the field of pharmacy compounding by completing Professional Compounding Centers of America C3 course.

Heather has a special interest in topical pain management and has been able to help a great number of patients in this compounding area.  Heather is currently completing a Pain Management Certificate through American Society of Hospital Pharmacists (ASHP). Heather has also attended numerous national and international seminars on pharmaceutical compounding in recent years.  Heather has most recently expanded her compounding knowledge by completing Hazardous and Non-Hazardous Low and Medium Risk Sterile Compound Verification and Housekeeping Theory training. 

Noelle Patten is Associate Registrar- Quality Assurance at the Newfoundland and Labrador Pharmacy Board (NLPB). Noelle graduated from the Memorial University School of Pharmacy in 2006, completed a Masters in Health Management at McMaster University in 2018, and achieved a Certified Health Executive Designation with the Canadian College of Health Leaders in 2019.  Noelle started her career in community pharmacy, which she enjoyed for eight years. She joined NLPB in 2014, initially as a practice advisor and moved into her current role in 2015. Her primary responsibility is development and oversight of the NLPB Quality Assurance Program, which includes practice site assessment programs for community and hospital pharmacies, and professional development requirements for registrants.

Noelle also oversees registration and licencing processes and assists with the development and implementation of regulatory standards and guidelines. In terms of non-sterile compounding, Noelle represents NLPB on the National Association of Pharmacy Regulatory Authorities (NAPRA) non-sterile and sterile compounding task forces and is NLPB's lead for implementation of the standards in pharmacies in pharmacies throughout the province.

SESSION: Getting PrePared to Support Patients Seeking HIV Pre-Exposure Prophylaxis

Date and Time:
Saturday, September 26, 2020
10:00 a.m. to 11:00 a.m.

Presentation details:
The learning objectives for this presentation include:

  • Understand the rationale and evidence for the use of antiretrovirals to prevent HIV
  • Be familiar with the different types of PrEP regimens
  • Be familiar with access and drug coverage options for PrEP in NL

Presented by:
Debbie Kelly, BSc(Pharm), ACPR, Pharm D, FCSHP, AAHIVP

About the presenter:

Debbie Kelly is an Associate Professor in the School of Pharmacy and holds a cross appointment to the Discipline of Medicine, Faculty of Medicine, Memorial University of Newfoundland.  She is also the Special Advisor on Practice Innovation and the Director of the Medication Therapy Services Clinic, which is the province’s only “pharmacist clinic”.

Debbie has been providing care to patients with HIV infection since 1999, as the Clinical Pharmacotherapy Specialist to the provincial HIV program in NL. Debbie maintains an active research practice in pharmacist scope of practice and in HIV, acting as principal investigator on several studies including community pharmacist-offered point of care testing for HIV (the APPROACH study and APPROACH 2.0), and the Canadian Observational Cohort study in HIV (CANOC) for the NL site.  Recently, Debbie authored a chapter on HIV prevention for the Compendium of Therapeutic Choices for CPhA, which is of particular relevance to this continuing education event.

SESSION: Management of the Poisoned Patient

Date and Time:
Saturday, September 26, 2020
11:15 a.m. to 12:15 p.m.

Presentation Details:
The learning objectives for this presentation include:

  • Describe the role of the IWK Regional Poison Centre
  • Identify therapeutic errors with the potential for serious toxicity
  • Identify when to contact the Poison Centre
  • Discuss acetaminophen toxicity and management

Presented by:
Danielle Burns, BSc (Pharm), BSc (Biology)

About the presenter:

Danielle Burns is a pharmacist and Specialist in Poison Information at the IWK Regional Poison Centre.  She currently sits on Health Canada committees involved in developing a national surveillance website which will track poison exposures across Canada in real time.  Danielle’s passion for toxicology is driven by the unique scenarios which present each day.

 After completing a Bachelor of Science (Biology) from Mount Allison University, Danielle graduated from Dalhousie College of Pharmacy in 2009, and is part of the Memorial University PharmD for Working Professionals Class of 2021.  Upon graduation from Dalhousie College of Pharmacy, Danielle worked in community pharmacy and became a Certified Diabetes Educator, before moving to the Poison Centre in 2016.

Important Information:  PANL Virtual CE Program Policies

Definitions:

  • Regular member: refers to those with active PANL Membership – regular, associate, supporting, honorary
  • Student Member: refers to MUN School of Pharmacy students with active PANL membership. MUN Students (and students from other institutions) that are not PANL members must register at the full non-member rate.
  • Non-member: refers to any individual without active PANL membership.
  • Pharmacy Technicians: are eligible to register at the non-member rate

Cancellation/Refunds:

  • Registration fees are non-refundable. Should PANL change the date/time of a session due to speaker availability, refunds may be issued upon request for that session only. This is not applicable to those purchasing the entire program.
  • Refunds will not be available to individuals who experience technical difficulties on the user end.

Deadline to Register:

  • Deadline to register is Wednesday September 2, 2020.

Recorded Sessions:

  • Whenever possible, sessions will be recorded and made available online for registered participants to view until October 30, 2020. Sessions will then be removed and will no longer be available.
  • Please note that not all sessions are able to be recorded and will be ‘live’ only. This will be noted on the Conference program.

PANL members must register in advance for the Virtual CE Program. Recorded CE sessions will NOT be available to members who did not register for the Virtual CE Program and registrations will not be accepted at a later date.

Virtual CE Program Pricing:

All prices subject to HST

Sessions may be purchased separately or at a ‘full program’ discount.

1-hour sessions:

Regular Member:                    $20

Non-Member:                         $30

Student Member:                   No cost

2-hour session:

Regular Member:                    $30

Non-Member:                         $40

Student Member:                   No cost

Full program:

Regular Member:                    $120

Non-Member:                         $240

Student Member:                   No cost

Evaluation Forms and Certificates of Attendance:

Upon conclusion of each session, links to evaluation forms and certificates of attendance will be provide to session registrants.

Conference Sponsors